Healthcare -
Biotechnology - NASDAQ - US
$ 3.12
-8.5 %
$ 529 M
Market Cap
-1.32
P/E
RLAY - COST OF REVENUE
Cost of Revenue RLAY - Relay Therapeutics, Inc.
5.27 M
LAST VALUE
15.86%
2 YEAR CAGR
19.59%
5 YEAR CAGR
0.00%
10 YEAR CAGR